HomeInsightsStock Comparison

Procter Gamble Health Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Procter Gamble Health Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Last Updated on: Jun 03, 2025

Key Highlights

  • The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5742 as of 03 Jun 15:30.
  • The P/E Ratio of Procter & Gamble Health Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Procter & Gamble Health Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Procter & Gamble Health Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Procter & Gamble Health Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Procter & Gamble Health Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The dividend payout of Procter & Gamble Health Ltd changed from 150.27 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % to 113.33 % over 5 quarters. This represents a CAGR of 190.44% .

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Procter & Gamble Health Ltd

  • Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in year 1967.
  • The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
  • Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
  • The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
  • The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Procter & Gamble Health Ltd News Hub

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

30 May 2025 11:27

News

Procter & Gamble Health declare Quarterly Result

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 29...

Read more

27 Mar 2025 10:23

News

P&G Health gains as Q3 PAT jumps 26% YoY to Rs 91 cr; declares interim dividend of Rs 80/share

The company's revenue from operations remained flat to Rs 309.77 crore in Q3 FY25, compare...

Read more

12 Feb 2025 15:45

News

Board of Procter & Gamble Health recommends interim dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

12 Feb 2025 16:37

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 12...

Read more

28 Dec 2024 09:36

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 2024 09:59

Sun Pharmaceutical Industries Ltd News Hub

News

Board of Sun Pharmaceutical Industries appoints director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved...

Read more

23 May 2025 11:13

News

Sun Pharmaceutical Industries announces cessation of director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has noted th...

Read more

23 May 2025 11:14

News

Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quart...

Read more

23 May 2025 13:48

News

Sun Pharmaceuticals Industries AGM scheduled

Sun Pharmaceuticals Industries announced that the 33th Annual General Meeting(AGM) of the ...

Read more

23 May 2025 15:37

News

Board of Sun Pharmaceuticals Industries recommends final dividend

Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its...

Read more

22 May 2025 20:47

News

Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%

Sun Pharmaceutical Industries Ltd rose 2.83% today to trade at Rs 1733.95. The BSE Healthc...

Read more

13 May 2025 09:30

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Procter & Gamble Health Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Procter & Gamble Health Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Procter & Gamble Health Ltd is 9,558 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 401,864 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Procter & Gamble Health Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Sun Pharmaceutical Industries Ltd?

As of June 3, 2025, the Procter & Gamble Health Ltd stock price is INR ₹5758.05. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1674.9.

How do dividend payouts of Procter & Gamble Health Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions